Mantle cell lymphoma · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Fludarabine and Rituximab (FR) Variant #01 | — | R 34 157 | 28d | — | — | ~6 | ~R 204 943 indirect | — |
FCM Variant #01 | — | R 16 144 | 28d | — | — | ~6 | ~R 96 867 indirect | — |
CHOP (Prednisolone) Variant #01 | — | R 1 048 | 21d | — | ~11.8 mo | ~8 | ~R 8 383 PFS proxy · indirect | 1 |
3 of 3 regimens shown